Non-Pharmacological Methods for Reducing Pain During Vaccination in Infants
Launched by UNIVERSITY OF YALOVA · Mar 14, 2025
Trial Information
Current as of April 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to help reduce pain in infants during vaccinations without using medicines. The focus is on non-drug methods, specifically looking at how holding a baby close or breastfeeding might make the experience less painful. Nurses play an important role in managing pain for infants, and this research aims to find safe and effective ways to support them during vaccinations.
To participate in the study, infants need to be between 4 weeks and 6 months old, healthy, and scheduled for a vaccination. Parents must agree to take part in the study and provide consent. Babies should not have taken any pain-relieving medications in the last four hours and should have a normal body temperature. During the trial, parents can expect to see how these comforting methods could help their babies during the vaccination process. This research is important because it explores simple, cost-effective ways to support infants and their families during immunizations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being healthy,
- • Aged between 4 weeks and 6 months,
- • Parents have given verbal and written consent to participate in the study,
- • Born at term (37 weeks of gestation or later),
- • Scheduled for vaccination under the Ministry of Health's vaccination program,
- • Not having taken analgesics/antipyretics in the last 4 hours before the procedure,
- • Having a normal body temperature (between 36.5°C and 37.1°C).
- Exclusion Criteria:
- • Having a chronic or mental illness, or a congenital anomaly,
- • Being older than 6 months,
- • Having a body temperature above 37.1°C,
- • Receiving analgesics, sedatives, or any other medication.
Trial Officials
EMEL AVÇİN, Doctor
Principal Investigator
Yalova Unıversıty
About University Of Yalova
The University of Yalova, a prominent academic institution located in Turkey, is dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at improving healthcare outcomes and contributing to the scientific community. Its research initiatives are supported by a team of experienced professionals and state-of-the-art facilities, fostering a robust environment for the development and evaluation of novel therapeutic interventions. Through these efforts, the University of Yalova strives to enhance patient care and promote evidence-based practices in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yalova, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported